X-linked endothelial corneal dystrophy

A rare genetic disorder affecting the cornea

Template:Medical condition (new)

X-linked endothelial corneal dystrophy (XECD) is a rare genetic disorder that affects the cornea, the transparent front part of the eye. This condition is characterized by abnormalities in the endothelium, the innermost layer of the cornea, leading to corneal edema and vision impairment.

Pathophysiology

The corneal endothelium is responsible for maintaining corneal transparency by regulating fluid and solute transport between the aqueous humor and the stroma. In X-linked endothelial corneal dystrophy, mutations in the genes responsible for endothelial cell function lead to dysfunction and degeneration of these cells. This results in an imbalance of fluid regulation, causing corneal swelling and loss of transparency.

Genetics

XECD is inherited in an X-linked recessive pattern, meaning the defective gene is located on the X chromosome. Males, having only one X chromosome, are more severely affected, while females, with two X chromosomes, may be carriers and exhibit milder symptoms. The specific gene mutations associated with XECD have been identified in some cases, but the genetic basis of the disorder is not fully understood.

Clinical Features

Individuals with X-linked endothelial corneal dystrophy typically present with symptoms in early childhood. Common clinical features include:

• Corneal edema
• Photophobia (sensitivity to light)
• Blurred vision
• Corneal opacification

The severity of symptoms can vary, with some individuals experiencing significant vision impairment, while others may have only mild symptoms.

Diagnosis

Diagnosis of XECD is based on clinical examination and family history. Slit-lamp examination can reveal characteristic changes in the corneal endothelium. Genetic testing may be used to confirm the diagnosis by identifying mutations in the relevant genes.

Management

There is currently no cure for X-linked endothelial corneal dystrophy. Management focuses on alleviating symptoms and preserving vision. Treatment options may include:

• Hypertonic saline eye drops to reduce corneal edema
• Contact lenses to improve vision
• Corneal transplantation in severe cases

Regular monitoring by an ophthalmologist is essential to manage the condition effectively.

Prognosis

The prognosis for individuals with XECD varies depending on the severity of the condition. Early diagnosis and appropriate management can help maintain vision and improve quality of life.

Related pages

• Corneal dystrophy
• Genetic disorders
• Ophthalmology